Telix Pharmaceuticals Limited (TLX) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
1.9%

Telix Pharmaceuticals Limited (TLX) earned a return on invested capital of 1.9% in fiscal 2025 (the year ended December 31, 2025). That is 16.2 percentage points lower than the 18.1% of fiscal 2024. Figures as of 17 Nov 2026, 23:10 UTC, from Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
1.9%
Change on fiscal 2024
−16.2 pts
Highest on record
114.2%fiscal 2023
Lowest on record
1.9%fiscal 2025
Fiscal years on record
32023–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Telix Pharmaceuticals Limited return on invested capital (ROIC), in more detail

Across the 3 fiscal years on record (2023–2025), the highest was 114.2% in fiscal 2023 and the lowest 1.9% in fiscal 2025.

History · 3 fiscal years

Return on invested capital by fiscal year

Telix Pharmaceuticals Limited return on invested capital (ROIC), year by year

Telix Pharmaceuticals Limited (TLX) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
20251.9% 16.2 pts down
202418.1% 96.1 pts down
2023114.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

More on TLX

Telix Pharmaceuticals Limited, figure by figure

Telix Pharmaceuticals Limited (TLX) overview: price, valuation and scorecard

Telix Pharmaceuticals Limited return on invested capital (ROIC): questions and answers

What is Telix Pharmaceuticals Limited's return on invested capital?

Telix Pharmaceuticals Limited (TLX) earned a return on invested capital of 1.9% in fiscal 2025 (the year ended December 31, 2025). That is 16.2 percentage points lower than the 18.1% of fiscal 2024.

What are the highest and lowest return on invested capital figures on record for Telix Pharmaceuticals Limited?

Across the 3 fiscal years on record (2023–2025), the highest was 114.2% in fiscal 2023 and the lowest 1.9% in fiscal 2025.

How is Telix Pharmaceuticals Limited's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Telix Pharmaceuticals Limited (TLX) return on invested capital (ROIC)”, data as of 17 November 2026. https://funkfolio.com/stock/TLX/roic

Underlying data: Yahoo Finance.